NuVasive, Globus Medical and DePuy Synthes, part of Johnson & Johnson, are three leaders in the orthopedic and spine device space.
Here's how the device companies compare in three areas:
DePuy Synthes: $2.1 billion revenue in Q1 2021
NuVasive: $271.2 million net sales in Q1 2021
Globus Medical: $227.3 million net sales in Q1 2021
2. No. of employees
DePuy Synthes: 12,000
Globus Medical: 1,800
3. Executive leadership
DePuy Synthes: Aldo Denti, Company Group Chairman (2018 — present)
NuVasive: Chris Barry, CEO (2018 — present)
Globus Medical: David Demski, CEO (2017 — present)
DePuy Synthes: West Chester, Pa.
NuVasive: San Diego
Globus Medical: Audubon, Pa.
5. Year founded
DePuy Synthes: 1895
Globus Medical: 2003
6. Key spine, orthopedic products
DePuy Synthes: DePuy has an expansive portfolio including the Velys robotic-assisted solution, Attune total knee system and the Bi-Mentum Dual Mobility System.
NuVasive: NuVasive has a wide selection of spinal products including the eXtreme lateral interbody fusion procedure, Magec rods and Precice limb-lengthening system.
Globus Medical: Globus Medical's portfolio comprises a variety of spinal screws, plates, biologics and its flagship ExcelsiusGPS robot.
7. Notable news this year
DePuy Synthes: Velys received FDA clearance for use with the Attune knee system.
NuVasive: NuVasive submitted its Pulse system and associated robotics application for FDA clearance, which are expected to launch this summer.
Globus Medical: Globus Medical launched Creo One, the market's first robotic screw designed for spine surgery with ExcelsiusGPS.